Jump Financial »

Supernus Pharmaceuticals shares owned by Jump Financial

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Jump Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.7M 101k 46.50
2025-09-30 $294k 6.2k 47.79
2024-06-30 $903k 34k 26.75
2023-06-30 $851k 28k 30.06
2021-09-30 $342k 13k 26.63

More positions owned by Jump Financial

State Street SPDR S&P 500 ETF Trust Etf (SPY)
iShares Core S&P 500 ETF Etf (IVV)
Invesco QQQ Trust Series 1 Etf Call Option (QQQ)
Direxion Daily Semiconductor Bull 3X ETF Etf (SOXL)
iShares Russell 2000 ETF Etf Call Option (IWM)
Vanguard S&P 500 ETF Etf (VOO)
iShares iBoxx USD High Yield Corporate Bond ETF Etf Call Option (HYG)
Bloom Energy Corp Common Stock (BE)
Sandisk Corp Common Stock (SNDK)
iShares MSCI South Korea ETF Etf (EWY)
iShares 20 Year Treasury Bond ETF Etf Call Option (TLT)
Seagate Technology Holdings Common Stock (STX)
Super Micro Computer Convertible bond (Principal)
Western Digital Corp Common Stock (WDC)
Intel Corp Common Stock (INTC)

View all positions for Jump Financial

Top funds holding Supernus Pharmaceuticals

BlackRock
Millennium Management
Vanguard Portfolio Management
Armistice Capital
Vanguard Capital Management
Nomura Asset Management International
State Street Corporation
Dimensional Fund Advisors
Geode Capital Management
Stephens Investment Management Group
Renaissance Technologies
Loomis, Sayles and
Citadel Advisors
Two Sigma Investments
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals